CETP c.1321+153T>C

Variant ID: 16-57016302-T-C

NM_000078.2(CETP):c.1321+153T>C

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias.

Bmc Medical Genomics
Dron, Jacqueline S JS; Wang, Jian J; McIntyre, Adam D AD; Iacocca, Michael A MA; Robinson, John F JF; Ban, Matthew R MR; Cao, Henian H; Hegele, Robert A RA
Publication Date: 2020-02-10

Variant appearance in text: CETP: 1321+153T>C
PubMed Link: 32041611
Variant Present in the following documents:
  • 12920_2020_669_MOESM1_ESM.xlsx, sheet 3
View BVdb publication page



Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.

The Pharmacogenomics Journal
Choi, Jihoon J; Tantisira, Kelan G KG; Duan, Qing Ling QL
Publication Date: 2019-04

Variant appearance in text: rs8045701
PubMed Link: 30214008
Variant Present in the following documents:
  • NIHMS1503453-supplement-3.xlsx, sheet 1
View BVdb publication page



Assessment of established HDL-C loci for association with HDL-C levels and type 2 diabetes in Pima Indians.

Diabetologia
Nair, Anup K AK; Piaggi, Paolo P; McLean, Nellie A NA; Kaur, Manmeet M; Kobes, Sayuko S; Knowler, William C WC; Bogardus, Clifton C; Hanson, Robert L RL; Baier, Leslie J LJ
Publication Date: 2016-03

Variant appearance in text: rs8045701
PubMed Link: 26670163
Variant Present in the following documents:
  • Main text
View BVdb publication page